16 markets covered - Australia to Vietnam! Each extensive country report is updated quarterly and provides individual and highly-detailed analysis of the market.
Delivering proven decision support data
- Comprehensive: 16 markets covered - Australia to Vietnam!
- Current: updated regularly with the latest content
- Future: Original 5-year market forecasts and SWOT analysis
- Prospects: Our expert analyst's own critical assessment of the market
- Reliable: Rich statistical and primary source background data
Asia: the region of growth
Valued at US$65.3 billion in 2012, the 16 Asian medical markets are expected to expand at higher than average growth rates over the next few years. The Asian region is expected to achieve an above growth rate of 8.3% to 2017.
Total Asian Medical Device Market, 2012 (US$ Millions)
Diversity & growth characterise the Asian medical markets and the operating environments to be found across the region are extensively & critically evaluated in The Outlook for Medical Devices in Asia. This collection covers advanced markets such as Japan, Australia and New Zealand as well as emerging and fast growing economies such as Malaysia and Vietnam.
Often overshadowed by the twin economic giants of India and China, many other Asian markets are equally fast growing and import dependent, presenting sales and partnering opportunities now and in the future. Some of the highest double-digit market growth rates in the region will be seen in Indonesia and Vietnam.
Now you can easily evaluate these markets with The Outlook for Medical Devices in Asia. Each extensive country report provides individual and highly-detailed analysis of the market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access.
Save money with our custom packages!
About Espicom Business Intelligence
Espicom Business Intelligence is a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets.